BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

CSL Limited 

45 Poplar Road

Parkville  Victoria  3052  Australia
Phone: 61-3-9389-1911 Fax: 61-3-9389-1434


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Healthcare






 Company News
Apathy Sends Biotech Jobs Offshore, Says CSL Limited (CMXHF.PK) 8/18/2014 8:03:22 AM
ASLAN Pharmaceuticals Pte Ltd In-Licenses Novel Asthma Therapy From CSL Limited (CMXHF.PK) 5/13/2014 8:21:13 AM
CSL Limited (CMXHF.PK) Takes Unused Blood Components To Make Cholesterol Drug 11/20/2013 10:33:25 AM
CSL Limited (CMXHF.PK) and Plasma Protein Therapeutics Association Agree to Pay $64 Million to Settle Plasma-Derivative Protein Therapies Antitrust Case 10/11/2013 7:21:43 AM
CSL Behring Parent Company, CSL Limited (CMXHF.PK), Issues Fourth Corporate Responsibility Report 12/4/2012 9:00:45 AM
PharmaJet Enters into Strategic Collaboration With CSL Limited (CMXHF.PK) for Needle-Free Delivery of Influenza Vaccines 11/30/2012 11:47:50 AM
Novel Apolipoprotein A-I Therapy, CSL Limited (CMXHF.PK)112, May Represent New Option for Reducing Recurrent Heart Attack Risk, Early CSL Studies Show 11/5/2012 12:46:46 PM
CSL Limited (CMXHF.PK): Viral Component Likely Cause of Convulsions in Kids Given Fluvax 6/20/2012 7:12:50 AM
Xencor Receives Milestone Payment from CSL Limited (CMXHF.PK) Under Antibody Optimization Collaboration 4/19/2012 10:25:24 AM
CSL Limited (CMXHF.PK) Partners with US Agency on Key Study to Prevent Common Cause of Abnormalities in Newborns 12/8/2011 12:38:32 PM
123456